After paying $305m, Anne Wojcicki is back at the helm of 23andMe – the genetic data company she cofounded, ran, then left ...

Seven biotech unicorns are advancing AI-powered drug discovery and development—but must contend with a difficult investing ...

After a couple of months of non-stop litigation, counsel for the debtor at Paul, Weiss and for the acquirer—a newly formed ...

After the company filed for bankruptcy in March, this week, the sale of 23andMe was completed after previously being approved by a judge.

TTAM Research Institute acquires 23andMe in a $305 million bankruptcy sale, transitioning the DNA testing giant to a ...

An obesity drug from Hengrui Pharma and Kailera Therapeutics succeeded in a late-stage trial in China, while Anne Wojcicki’s ...

When it comes to groundbreaking biotech advancements, Eric Faw Intellia is a name you might wanna keep an eye on. This ...

CT is your last chance to file a claim with 23andMe for a 2023 data breach that may have compromised your genetic data.

MAIA Biotechnology enrolls first patient in expansion of phase 2 clinical trial for ateganosine in advanced non-small cell lung cancer: Chicago Friday, July 11, 2025, 12:00 Hrs [I ...

"It has always been a sale of DNA to a third party." TTAM Research won a bankruptcy auction for 23andMe’s assets in June, ...

Genetic testing company 23andMe can proceed with a US$305-million sale to the company’s co-founder Anne Wojcicki after a U.S. bankruptcy judge rejected California’s bid to delay the sale while the ...